BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24827427)

  • 1. Different calcium influx characteristics upon Kv1.3 and IKCa1 potassium channel inhibition in T helper subsets.
    Orbán C; Bajnok A; Vásárhelyi B; Tulassay T; Toldi G
    Cytometry A; 2014 Jul; 85(7):636-41. PubMed ID: 24827427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis.
    Toldi G; Bajnok A; Dobi D; Kaposi A; Kovács L; Vásárhelyi B; Balog A
    Immunobiology; 2013 Mar; 218(3):311-6. PubMed ID: 22705192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in the neonate.
    Toldi G; Treszl A; Pongor V; Gyarmati B; Tulassay T; Vásárhelyi B
    Int Immunol; 2010 Sep; 22(9):769-74. PubMed ID: 20601376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte activation in type 1 diabetes mellitus: the increased significance of Kv1.3 potassium channels.
    Toldi G; Vásárhelyi B; Kaposi A; Mészáros G; Pánczél P; Hosszufalusi N; Tulassay T; Treszl A
    Immunol Lett; 2010 Sep; 133(1):35-41. PubMed ID: 20603149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium influx kinetics, and the features of potassium channels of peripheral lymphocytes in primary Sjögren's syndrome.
    Legány N; Toldi G; Orbán C; Megyes N; Bajnok A; Balog A
    Immunobiology; 2016 Nov; 221(11):1266-72. PubMed ID: 27346388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis by flow cytometry of calcium influx kinetics in peripheral lymphocytes of patients with rheumatoid arthritis.
    Bajnok A; Kaposi A; Kovács L; Vásárhelyi B; Balog A; Toldi G
    Cytometry A; 2013 Mar; 83(3):287-93. PubMed ID: 23335202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in healthy pregnancy and preeclampsia.
    Toldi G; Stenczer B; Treszl A; Kollár S; Molvarec A; Tulassay T; Rigó J; Vásárhelyi B
    Am J Reprod Immunol; 2011 Feb; 65(2):154-63. PubMed ID: 20649894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of Kv1.3 and IKCa1 channel inhibition on cytokine production and calcium influx of T lymphocytes in rheumatoid arthritis and ankylosing spondylitis.
    Toldi G; Munoz L; Herrmann M; Schett G; Balog A
    Immunol Res; 2016 Apr; 64(2):627-31. PubMed ID: 26280090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte calcium influx kinetics in multiple sclerosis treated without or with interferon β.
    Toldi G; Folyovich A; Simon Z; Zsiga K; Kaposi A; Mészáros G; Tulassay T; Vásárhelyi B
    J Neuroimmunol; 2011 Aug; 237(1-2):80-6. PubMed ID: 21764463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium Influx Kinetics and the Characteristics of Potassium Channels in Peripheral T Lymphocytes in Systemic Sclerosis.
    Toldi G; Legány N; Ocsovszki I; Balog A
    Pathobiology; 2020; 87(5):311-316. PubMed ID: 32911471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
    Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassium channels as therapeutic targets for autoimmune disorders.
    Wulff H; Beeton C; Chandy KG
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):640-7. PubMed ID: 14579513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of aging on calcium influx and potassium channel characteristics of T lymphocytes.
    Kollár S; Berta L; Vásárhelyi ZE; Balog A; Vásárhelyi B; Rigó J; Toldi G
    Oncotarget; 2015 May; 6(15):13750-6. PubMed ID: 25948778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
    Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
    Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C-dependent activation of CaV1.2 channels selectively controls human TH2-lymphocyte functions.
    Robert V; Triffaux E; Paulet PE; Guéry JC; Pelletier L; Savignac M
    J Allergy Clin Immunol; 2014 Apr; 133(4):1175-83. PubMed ID: 24365142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potassium channels in T lymphocytes: therapeutic targets for autoimmune disorders?
    Vianna-Jorge R; Suarez-Kurtz G
    BioDrugs; 2004; 18(5):329-41. PubMed ID: 15377175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Th1 and Th2 lymphocytes are distinguished by calcium flux regulation during the first 10 min of lymphocyte activation.
    Toldi G; Kaposi A; Zsembery Á; Treszl A; Tulassay T; Vásárhelyi B
    Immunobiology; 2012 Jan; 217(1):37-43. PubMed ID: 21899918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel alpha-KTx peptides from the venom of the scorpion Centruroides elegans selectively blockade Kv1.3 over IKCa1 K+ channels of T cells.
    Olamendi-Portugal T; Somodi S; Fernández JA; Zamudio FZ; Becerril B; Varga Z; Panyi G; Gáspár R; Possani LD
    Toxicon; 2005 Sep; 46(4):418-29. PubMed ID: 16026809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Voltage-dependent potassium channel and calcium-activated potassium channel current changes of peripheral blood T-lymphocytes from hypertensive patients in Xinjiang Kazakh].
    Zhang QB; Zhang YM; Cheng LF; Yuan QY; Zhang GM; Liang P; Gou F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Dec; 41(12):1020-4. PubMed ID: 24524604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kv1.3 lymphocyte potassium channel inhibition as a potential novel therapeutic target in acute ischemic stroke.
    Folyovich A; Biro E; Orban C; Bajnok A; Vasarhelyi B; Toldi G
    CNS Neurol Disord Drug Targets; 2014; 13(5):801-6. PubMed ID: 25012622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.